Evaluation of the VersaTREK system compared to the bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 50, Issue 2, 2012, Pages 488-491

  Espasa, Mateu ^a,b   Salvado M ^b,c   Vicente, E ^b,c   Tudo G ^d,e   Alcaide, F ^d,f   Coll, P ^b,g   Martin Casabona, N ^b,h   Torra, M ^a,b   Fontanals, D ^a,b   Gonzalez Martin J ^a,b  

^a Servicio de Oncología Médica   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Laboratori de Referencia de Catalunya   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; BACTEC 960 MYCOBACTERIAL GROWTH INDICATOR TUBE SYSTEM; BACTERIAL STRAIN; BACTERIUM ISOLATE; DNA SEQUENCE; DRUG SENSITIVITY; GENE MUTATION; GENOTYPE; INTERMETHOD COMPARISON; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RELIABILITY; VERSATREK SYSTEM;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84856183183     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06432-11     Document Type: Article

References (26)

1. Ardito F, Posteraro B, Sanguinetti M, Zanetti S, Fadda G. 2001. Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 39:4440-4444. (Pubitemid 33117136)
2. Aziz MA, et al. 2006. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 368:2142-2154. (Pubitemid 44914009)
3. Becton Dickinson. 2002. BACTEC MGIT 960 PZA kit. http://www.bd.com/ds/ technicalCenter/clsi/clsi-960pza.pdf.
4. Becton Dickinson. 2002. BACTEC MGIT 960 SIRE kits. http://www.bd.com/ds/ technicalCenter/clsi/clsi-960pza.pdf.
5. Bemer P, Palicova F, Rusch-Gerdes S, Drugeon HB, Pfyffer GE. 2002. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 40:150-154. (Pubitemid 34027617)
6. Bergmann JS, Woods GL. 1998. Evaluation of the ESP Culture System II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs. J. Clin. Microbiol. 36:2940-2943. (Pubitemid 28429418)
7. Delas MA, et al. 2001. Comparative study of 3 tests for susceptibility of Mycobacterium tuberculosis to first-line antituberculous drugs. Rev. Esp. Quimioter. 14:40-46. (Pubitemid 32463548)
8. Falzon D, et al. 2011. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur. Respir. J. 38:516-528.
9. Ganeswrie R, Chui CS, Balan S, Puthucheary SD. 2004. Comparison of BACTEC MGIT 960 system and BACTEC 460 TB system for growth and detection of Mycobacteria from clinical specimens. Malays. J. Pathol. 26: 99-103.
10. Garrigo M, et al. 2007. Multicenter laboratory evaluation of the MB/ BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 45:1766-1770. (Pubitemid 46933904)
11. LaBombardi VJ. 2002. Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide. J. Clin. Microbiol. 40:2238-2239. (Pubitemid 34596416)
12. Laszlo A, Rahman M, Espinal M, Raviglione M, WHO/IUATLD Network of Supranational Reference Laboratories. 2002. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLDSupranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int. J. Tuberc. Lung Dis. 6:748-756. (Pubitemid 34988044)
13. Piersimoni C, Olivieri A, Benacchio L, Scarparo C. 2006. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J. Clin. Microbiol. 44:20-28. (Pubitemid 43100573)
14. Roberts GD, et al. 1983. Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J. Clin. Microbiol. 18:689-696. (Pubitemid 13004221)
15. Ruiz P, Zerolo FJ, Casal MJ. 2000. Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method. J. Clin. Microbiol. 38:4663-4664. (Pubitemid 32244572)
16. Scarparo C, Ricordi P, Ruggiero G, Piccoli P. 2004. Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method. J. Clin. Microbiol. 42:1109-1114. (Pubitemid 38332833)
17. Siddiqi S. 2004. BACTEC MGIT 960 PZA. Susceptibility testing for Mycobacterium tuberculosis, p 7.8.6.1-7.8.6.4. In Isenberg HD (ed), Clinical microbiology procedures handbook, 2nd ed, vol 1. American Society for Microbiology, Washington, DC.
18. Siddiqi S. 2004. BACTEC MGIT 960 SIRE. Nonradiometric susceptibility testing for Mycobacterium tuberculosis, p 7.8.5.1-7.8.5.5. In Isenberg HD (ed), Clinical microbiology procedures handbook, 2nd ed, vol 1. American Society for Microbiology, Washington, DC.
19. Tarrand JJ, Groschel DH. 1985. Evaluation of the BACTEC radiometric method for detection of1%resistant populations of Mycobacterium tuberculosis. J. Clin. Microbiol. 21:941-946. (Pubitemid 15058943)
20. Tortoli E, Benedetti M, Fontanelli A, Simonetti MT. 2002. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J. Clin. Microbiol. 40:607-610. (Pubitemid 34130888)
21. VersaTREK. 2010. VersaTREK Myco PZA kit, 7116-70. http://www.trekds.com/ techDocsVT/techInsert/TI-VersaTREK-Myco-PZA-Kit-L-TDST015-7.pdf.
22. VersaTREK. 2010. VersaTREK Myco Streptomycin 7120-42. http://www.trekds.com/techDocsVT/techInsert/TI-VersaTREK-Myco-Streptomycin-L- TDST020-5.pdf.
23. VersaTREK. 2010. VersaTREK Myco susceptibility kit, 7115-60. http://www.trekds.com/techDocsVT/techInsert/TI-VersaTREK-Myco-Susceptibility- Kit-L-TDST014-8.pdf.
24. World Health Organization. 2008. Anti-tuberculosis drug resistance in the world: report 4. WHO/HTM/TB/2008.394. World Health Organization, Geneva, Switzerland.
25. World Health Organization. 2010. Global tuberculosis control: WHO report 2010. WHO/HTM/TB/2010.7. World Health Organization, Geneva, Switzerland.
26. Wright A, et al. 2009. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373:1861-1873.